Proposed Rule Brings Fair Reimbursement One Step Closer


Expected to save taxpayers billions over the next 5 years, the proposed rule would sync reimbursement with what pharmacies actually pay.

Expected to save taxpayers billions over the next 5 years, the proposed rule would sync reimbursement with what pharmacies actually pay.

The Centers for Medicare & Medicaid Services (CMS) issued a proposed rule that could save the federal-state Medicaid program $17.7 billion over a 5-year period. The program will change how states reimburse pharmacies for drugs that they purchase for Medicaid patients. Rather than reimbursing states for the drugs based on pharmaceutical company list prices, states would reimburse pharmacies based on the price they paid for the medicines. This idea is based on an existing program that has been used successfully in Alabama.

The CMS proposed rule also includes language that would allow the federal government to help states determine the wholesale price for drugs by creating a national database of wholesale drug prices. Additionally, the rule would increase what drug companies currently pay states for purchased drugs, and drugs purchased through the Medicaid managed care program would be covered by the rebates. The proposed changes were called for in the Patient Protection and Affordable Care Act.

“There’s a rich history of individual pharmaceutical companies getting nailed in court for defrauding state governments in pricing,” says Matt Salo, director of the National Association of Medicaid Directors. The lack of transparency makes it difficult for states that are trying to reduce their pharmaceutical bills.

States have taken a number of actions to reduce prescription drugs expense, including promoting generic medications for patients on Medicaid and limiting beneficiaries’ refills or prescriptions. A Kaiser Family Foundation survey found that almost every state took action last year to decrease spending on prescription drugs.

For pharmacists, this rule could mean fair reimbursement, but until the details are known, pharmacists should keep an eye on this bill. Specifically, pharmacists will want to watch the filing requirements and processes proposed to implement this program and keep in touch with their state representatives as this moves into regulatory review. In addition, starting February 2, 2012, this Proposed Rule can be viewed on the Federal Register Web site. The public comment period ends April 2, 2012, and CMS plans to issue a final rule in 2013.

Related Videos
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U -
Image credit: Andrea Izzotti
Inflation Reduction Act is shown using the text and the US flag - Image credit: Andrii |
Pharmacy Interior | Image Credit: Tyler Olson -
Male pharmacist selling medications at drugstore to a senior woman customer | Image Credit: Zamrznuti tonovi -
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen |
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store - Image credit: C Daniels/ |
Image credit: fidaolga -
Pharmacists checking inventory at hospital pharmacy- Image credit: Jacob Lund |
Young male pharmacist giving prescription medications to senior female customer in a pharmacy | Image Credit: Zamrznuti tonovi -
© 2023 MJH Life Sciences

All rights reserved.